![Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6994129/bin/jci-130-121127-g081.jpg)
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC
![Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6994129/bin/jci-130-121127-g085.jpg)
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. - Abstract - Europe PMC
![PDF) Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction PDF) Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction](https://i1.rgstatic.net/publication/45630219_Early_Diagnosis_of_Invasive_Aspergillosis_in_Neutropenic_Patients_Comparison_between_Serum_Galactomannan_and_Polymerase_Chain_Reaction/links/555d1c0908ae9963a1121228/largepreview.png)